Hasil Pencarian - Sanjeev Roy

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Calotropis procera Latex Extract Affords Protection against Inflammation and Oxidative Stress in Freund's Complete Adjuvant-Induced Monoarthritis in Rats

    Calotropis procera Latex Extract Affords Protection against Inflammation and Oxidative Stress in Freund's Complete Adjuvant-Induced Monoarthritis in Rats oleh Vijay L. Kumar, Sanjeev Roy

    Diterbitkan 2007-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

    Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS) oleh Francesco Patti, Andrea Visconti, Antonio Capacchione, Sanjeev Roy, Maria Trojano

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    P102 Safety evaluation from an ongoing randomized, double-blind, multiple-ascending dose phase Ib study of enpatoran versus placebo in patients with active systemic or cutaneous lupus erythematosus (SLE/CLE)

    P102 Safety evaluation from an ongoing randomized, double-blind, multiple-ascending dose phase Ib study of enpatoran versus placebo in patients with active systemic or cutaneous lu... oleh Torsten Witte, Sanjeev Roy, Joerg Wenzel, Nadezda Abramova, Dominika Weinelt, Deborah Denis

    Diterbitkan 2024-03-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Predicting disease activity in patients with multiple sclerosis: An explainable machine‐learning approach in the Mavenclad trials

    Predicting disease activity in patients with multiple sclerosis: An explainable machine‐learning approach in the Mavenclad trials oleh Sreetama Basu, Alain Munafo, Ali‐Frederic Ben‐Amor, Sanjeev Roy, Pascal Girard, Nadia Terranova

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a analysis

    Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a analysis oleh Jens Kuhle, David Leppert, Giancarlo Comi, Nicola de Stefano, Ludwig Kappos, Mark S. Freedman, Andrea Seitzinger, Sanjeev Roy

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    P71 Treatment patterns, healthcare resource utilization and related costs of patients with discoid lupus erythematosus (DLE) or subacute cutaneous lupus erythematosus (SCLE) in the United States: a cohort study in the Merative™ MarketScan® database

    P71 Treatment patterns, healthcare resource utilization and related costs of patients with discoid lupus erythematosus (DLE) or subacute cutaneous lupus erythematosus (SCLE) in the... oleh Ying Sun, Benjamin F Chong, Caroline Foch, Sanjeev Roy, Dominika Weinelt, Sabrina de Souza, Xiaoxue Chen, Jeffrey M Muir

    Diterbitkan 2024-03-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Model‐based meta‐analysis using latent variable modeling to set benchmarks for new treatments of systemic lupus erythematosus

    Model‐based meta‐analysis using latent variable modeling to set benchmarks for new treatments of systemic lupus erythematosus oleh Kosalaram Goteti, Ramon Garcia, William R. Gillespie, Jonathan French, Lena Klopp‐Schulze, Ying Li, Cristina Vazquez Mateo, Sanjeev Roy, Oliver Guenther, Lisa Benincosa, Karthik Venkatakrishnan

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    LP-183 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW)

    LP-183 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW) oleh Victoria P Werth, Eric F Morand, Melinda Przetak, Flavie Moreau, Cristina Vazquez-Mateo, Andrew Bender, Sanjeev Roy, Aditee Deshpande, Ankita Deshmukh, Bharat Vaidyanathan, Mukhy Khursheed, David R Pearson

    Diterbitkan 2023-07-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW)

    1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) oleh Victoria P Werth, Eric F Morand, Melinda Przetak, Flavie Moreau, Cristina Vazquez-Mateo, Andrew Bender, Sanjeev Roy, Aditee Deshpande, Ankita Deshmukh, Bharat Vaidyanathan, Mukhy Khursheed, David R Pearson

    Diterbitkan 2022-12-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Enpatoran in COVID‐19 pneumonia: Safety and efficacy results from a phase II randomized trial

    Enpatoran in COVID‐19 pneumonia: Safety and efficacy results from a phase II randomized trial oleh John E. McKinnon, Joel Santiaguel, Claudia Murta de Oliveira, Dongzi Yu, Mukhy Khursheed, Flavie Moreau, Lena Klopp‐Schulze, Jamie Shaw, Sanjeev Roy, Amy H. Kao, the ANEMONE Study Team

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: